Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Huoxue Huatan Granule for COPD with Chronic Respiratory Failure
NCT04208581Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yiqi Huoxue Huatan in chronic obstructive pulmonary disease (COPD), chronic respiratory failure, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
Yiqi Huoxue Huatan
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic respiratory failure
Beyond the preview
Go deeper on NCT04208581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208581.